海外の治験の状況「1」での検索結果
2657件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not Recruiting
- A study of the safety and effectiveness of a new treatment from human blood source that replaces the missing clotting factor VIII, including determination of drug level in hemophilia A patients.
- Hemophilia A. MedDRA version: 17.1 Level: LLT Classification code 10060612 Term: Hemophilia A System Organ Class: 100000004850 ;Therapeutic area: Body processes [G] - Genetic Phenomena [G05]
- Australia, Austria, Canada, Chile, Czech Republic, European Union, Germany, Hungary, Italy, Japan, Korea, Republic of, Lebanon, Malaysia, Netherlands, Philippines, Poland, Russian Federation, South Africa, Spain, Sweden, Switzerland, Ukraine, United Kingdom, United States
- 2011-07-28
Authorised
- An open study comparing the efficacy of S-1 and Cisplatin in combination versus 5-FU and Cisplatin in patients with Gastric cancer not previously treated with chemotherapy.
- Metastatic Diffuse Gastric Cancer MedDRA version: 17.0 Level: PT Classification code 10063916 Term: Metastatic gastric cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Belgium, Brazil, Bulgaria, Colombia, Croatia, Estonia, Germany, Hungary, Italy, Lithuania, Mexico, Poland, Portugal, Romania, Russian Federation, South Africa, Spain, Ukraine, United Kingdom, United States
- 2010-12-03
Recruiting
- Biomarker for Hurler Disease: BioHurler
- Mucopolysaccharidosis Type I;Gargoylism;Metabolism, Inborn Errors
- Egypt, Germany, India, Pakistan
- 2014-10-23
Not Recruiting
- Albiglutide Versus Placebo as Add-on to Intensified Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Mellitus
- Diabetes mellitus type 2 MedDRA version: 17.0 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus System Organ Class: 100000004861 ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Brazil, Canada, France, Germany, Hungary, Italy, Korea, Republic of, Mexico, Philippines, Poland, South Africa, Spain, United Kingdom, United States
- 2014-10-01
Authorised
- A Phase 1/2 Study of Venetoclax in Combination with Low-Dose Cytarabine in Treatment-Naïve Subjects with Acute Myelogenous Leukemia Who Are = 60 Years of Age and Who Are Not Eligible for Standard Anthracycline-Based Induction Therapy
- Acute Myelogenous Leukemia MedDRA version: 20.0 Level: LLT Classification code 10001941 Term: AML System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Germany, Italy, United States
- 2014-09-24
Not recruiting
- An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Untreated Males With Severe Hemophilia A
- Hemophilia A;Hemophilia A
- Australia, Brazil, Canada, Denmark, France, Germany, Ireland, Italy, Netherlands, New Zealand, Poland, Spain, Sweden, United Kingdom, United States
- 2014-08-29
Not recruiting
- Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia
- cKIT-positive Solid Tumors;AML
- Australia, Belgium, France, Germany, Italy, Netherlands, Spain, United States
- 2014-08-08
Recruiting
- Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Observation After Curative Intent Resection of Cholangiocarcinoma and Muscle Invasive Gall Bladder Carcinoma (ACTICCA-1 Trial)
- Cholangiocarcinoma # Gall Bladder Carcinoma;C22.1 - Malignant neoplasm: Intrahepatic bile duct carcinoma;C24.0 - Malignant neoplasm: Extrahepatic bile duct;C24.8 - Malignant neoplasm: Overlapping lesion of biliary tract
- Australia, Germany, Netherlands, United Kingdom
- 2014-08-01
Not Recruiting
- This clinical trial is to study Immune Tolerance Induction, by Factor VIII concentrate containing von Willebrand factor, in severe or moderate haemophilia A patients with inhibitors.
- Severe or moderate haemophilia A patients with inhibitors.
- Egypt, India
- 2014-07-18
Recruiting
- Evaluation of the Role of Follicular Sensitivity Index in the Prediction of Pregnancy in Women Undergoing ICSI/IVF Without Polycystic Ovarian Syndrome
- Subfertility;Assisted Reproduction;Subfertility;Assisted Reproduction;Subfertility;Assisted Reproduction;Subfertility;Assisted Reproduction
- Egypt
- 2014-06-04
Not recruiting
- N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan
- Neuroblastoma
- Australia, Canada, United States
- 2014-01-02
Not Recruiting
- A clinical study involving people with severe haemophilia A to look at how two different strengths of an experimental replacement factor VIII protein (known as rFVIIIFc) are processed by the body and how safe it is to take.
- Hemophilia A MedDRA version: 18.0 Level: LLT Classification code 10053753 Term: Hemophilia A without inhibitors System Organ Class: 100000004850 MedDRA version: 18.0 Level: LLT Classification code 10060612 Term: Hemophilia A System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Australia, South Africa, United Kingdom, United States
- 2013-12-06
Not recruiting
- Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
- Tuberous Sclerosis;Subependymal Giant Cell Astrocytoma;Tuberous Sclerosis;Subependymal Giant Cell Astrocytoma;Tuberous Sclerosis;Subependymal Giant Cell Astrocytoma;Tuberous Sclerosis;Subependymal Giant Cell Astrocytoma
- Australia, Belgium, Canada, Germany, Italy, Netherlands, Poland, Russian Federation, United Kingdom, United States
- 2008-11-12
Recruiting
- A PHASE IIIB, RANDOMIZED, OPEN-LABEL STUDY OF THE SAFETY AND EFFICACY OF DOLUTEGRAVIR OR EFAVIRENZ EACH ADMINISTERED WITH TWO NRTIS IN HIV-1-INFECTED ANTIRETROVIRAL THERAPY-NAÏVE ADULTS STARTING TREATMENT FOR RIFAMPICIN-SENSITIVE TUBERCULOSIS
- -B200 HIV disease resulting in mycobacterial infection HIV disease resulting in mycobacterial infection;HIV disease resulting in mycobacterial infection
- Argentina, Brazil, Mexico, Peru, Russian Federation, South Africa, Thailand
- 2015-04-30
Not Recruiting
- Research for biomarkers of serum/CSF in patients with rapidly progressive dementia including human prion disease
- rapidly progressive dementia including human prion disease
- Asia(except Japan), Australia, Europe, Japan, North America, South America
- 2015-04-01
Not Recruiting
- A Study to evaluate the Efficacy and Safety of Insulin Detemir against Insulin NPH along With Metformin and Diet/Exercise in Children and Adolescents having Type 2 Diabetes
- Type 2 diabetes mellitus
- Argentina, Australia, Belgium, Brazil, Canada, China, Croatia, Denmark, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Poland, Republic of Korea, Russian Federation, Serbia, South Africa, Spain, Taiwan, The former Yugoslav Republic of Macedonia, Turkey, United Kingdom, United States of America
- 2015-02-16
Authorised
- The purpose of this study is to evaluate a drug (LUM001) that may help treat the liver and control itching in Alagille Syndrome. In this study, all children who are eligible to enrol will take study drug for 18 weeks, followed by a 4 week period where they will either take LUM001 or placebo. After this 4 week period, all patients will go back on active study drug treatment for the remaining 26 weeks.
- Alagille Syndrome br>MedDRA version: 17.0 Level: PT Classification code 10053870 Term: Alagille syndrome System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Australia, Canada, Spain
- 2014-05-22
Authorised
- Study to collect data to further monitor whether the treatment triggers an immune reaction (i.e. development of antibodies, so called “inhibitors” directed against factor 8), to further investigate how well Human-cl rhFVIII prevents and stops bleeding episodes, and to monitor if it is safe and well tolerated in the treatment on a long-term basis.
- Severe Haemophilia A MedDRA version: 16.1 Level: LLT Classification code 10018938 Term: Haemophilia A (Factor VIII) System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Brazil, Canada, Colombia, France, Georgia, Germany, India, Moldova, Republic of, Morocco, Poland, Russian Federation, Spain, Ukraine, United Kingdom, United States, Venezuela, Bolivarian Republic of
- 2013-11-20
Not Recruiting
- A PHASE III, RANDOMISED, DOUBLE-BLIND, MULTICENTRE, PARALLEL-GROUP, NON-INFERIORITY STUDY EVALUATING THE EFFICACY, SAFETY, AND TOLERABILITY OF DOLUTEGRAVIR PLUS LAMIVUDINE COMPARED TO DOLUTEGRAVIR PLUS TENOFOVIR/EMTRICITABINE IN HIV-1-INFECTED TREATMENT-NAÏVE ADULTS
- -B24 Unspecified human immunodeficiency virus [HIV] disease Unspecified human immunodeficiency virus [HIV] disease;Unspecified human immunodeficiency virus [HIV] disease
- Argentina, Australia, Belgium, Canada, France, Germany, Italy, Mexico, Poland, Portugal, Romania, Russian Federation, South Africa, Spain, Switzerland, Taiwan, Ukraine, United Kindgdom, United States
- 2016-12-19
Not recruiting
- A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification
- Diabetes;Diabetes Mellitus, Type 2
- Algeria, Czech Republic, Czechia, India, Russian Federation, Serbia, Turkey, United States
- 2016-09-15